Nantahala Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
Senti Biosciences, Inc. Common stock, par value $0.0001 per share
Symbol
SNTI
Shares outstanding
27,339,901 shares
Disclosed Ownership
2,220,000 shares
Ownership
8.1%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:41:42 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Quoteable Key Fact

"Nantahala Capital Management, LLC disclosed 8.1% ownership in Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI) on 31 Mar 2025."

Quick Takeaways

  • Nantahala Capital Management, LLC filed SCHEDULE 13G/A for Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI).
  • Disclosed ownership: 8.1%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 15 May 2025, 16:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 8.1% 2,220,000 0 2,220,000 /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 8.1% 2,220,000 0 2,220,000 /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 8.1% 2,220,000 0 2,220,000 /s/ Daniel Mack Daniel Mack